Effectiveness of Nurse Led Intervention on Health Related Quality of Life among Children with Sickle Cell Disease in Oman: A Pilot Study

Table 3

Comparison between pre-test and post-test HRQOL score of participants in the intervention and control group.

Age group	Dimensions of HRQOL	Test				Mean difference	Wilcoxon signed rank test	Test				Mean difference	Wilcoxon signed rank test
		Pre-test		Post-test				Pre test		Post test
		Mean	SD	Mean	SD
8–12 years child report	Pain and hurt	30.67	4.10	40.81	5.46	10.14		29.63	5.74	32.00	8.52	2.37
							Pain impact						26.50	4.98	32.30	5.08	5.8		25.37	4.46	28.20	7.84	2.83
	Pain management and control	29.27	5.14	43.33	6.13	14.06			27.87	8.25	32.47	6.05						4.6
							Worry I	33.13					6.59	41.93	5.64	8.8			31.20	5.48	34.70	6.20	3.5
	Worry II	38.47	7.85	44.83	7.77	6.36				37.03	6.62	39.27					6.26	2.24
							Emotions	38.73	7.97				46.50	7.25	7.77				35.93	6.59	36.33	8.24	0.4
	Treatment	33.81	4.57	44.70	10.01	10.89					31.67	9.04				34.56	7.00	2.89
							Communication I	42.56	4.10	50.22			10.19	7.66					40.64	4.46	44.13	14.67	3.49
	Communication II	25.27	3.05	36.93	11.47	11.66						23.73			2.75	27.55	9.36	3.82
							8–12 years parent report	Pain and hurt	29.15	4.49	38.19		6.61	9.04						27.59	7.08	29.00	6.20	1.41
	Pain impact	27.00	3.68	33.37	7.01	6.37									26.53	9.62	27.77	9.57	1.24
								Pain management and control	28.33	14.54	42.97	9.14	14.64							26.67	13.25	29.83	7.76	3.16
	Worry I	34.00	7.61	45.00	9.45	11.00									33.33	8.34	34.20	6.88	0.87
								Worry II	39.50	12.23	44.00	7.80	4.50							36.67	17.97	37.33	11.05	0.66
	Emotions	36.67	8.80	41.67	7.72	5.00									35.00	11.76	38.67	12.42	3.67
								Treatment	33.65	9.89	37.37	7.33	3.72							30.47	6.92	32.08	9.38	1.61
	Communication I	36.29	7.83	38.89	6.34	2.60									35.20	9.54	37.51	9.88	2.31
								Communication II	28.89	6.95	32.53	6.73	3.64							25.00	9.45	28.11	11.11	3.11

Significant at , significant at , significant at .